These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15629033)

  • 1. A strategy for searching antigenic regions in the SARS-CoV spike protein.
    Ren Y; Zhou Z; Liu J; Lin L; Li S; Wang H; Xia J; Zhao Z; Wen J; Zhou C; Wang J; Yin J; Xu N; Liu S
    Genomics Proteomics Bioinformatics; 2003 Aug; 1(3):207-15. PubMed ID: 15629033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
    Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; Hsiang CY
    Biochem Biophys Res Commun; 2004 Jan; 313(4):938-47. PubMed ID: 14706633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage.
    Lee YC; Leu SJ; Hung HC; Wu HH; Huang IJ; Hsieh WS; Chiu WT; Hsieh MS; Cheng TF; Yang YY
    Vet Immunol Immunopathol; 2007 May; 117(1-2):75-85. PubMed ID: 17360045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prokaryotic expression of SARS coronavirus spike protein and construction of its DNA vaccine].
    Li JN; Xiang KJ; Zhou R; Huang CH; Ding YQ; Zeng QY; Zhong QP
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):33-6. PubMed ID: 15683993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
    Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
    Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
    Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
    J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cloning, purification, and antigenic characterization of three recombinant fragments derived from SARS-CoV S1 domain].
    Mei YB; Liao ZY; Wang YD; Zhang LY; Xu H; Yuen KY; Che XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):275-8. PubMed ID: 16261215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
    J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and characterization of the epitopes of SARS coronavirus spike protein].
    Fang K; Zhong LS; Ma RH; Wang SC; Pan ZC; Zhang YK; He Q; Zhao YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1007-9. PubMed ID: 17988578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of recombinant spike protein of SARS-coronavirus in vaccinia virus and analysis of its immunogenicity].
    Hu S; Wang QH; Wang XJ; Wang XM; Bu ZG
    Bing Du Xue Bao; 2007 Jul; 23(4):287-91. PubMed ID: 17894231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species.
    Yu M; Stevens V; Berry JD; Crameri G; McEachern J; Tu C; Shi Z; Liang G; Weingartl H; Cardosa J; Eaton BT; Wang LF
    J Immunol Methods; 2008 Feb; 331(1-2):1-12. PubMed ID: 18191140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
    He Y; Li J; Heck S; Lustigman S; Jiang S
    J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Receptor-binding ability of fragments 260-600 and 397-796 of SARS-associated coronavirus spike protein].
    Wei HY; Wang JW; Ou YJ; Wang YB; Qu JG; Zhao WM; Hong T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):353-7. PubMed ID: 16415994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of polyclonal antibody against severe acute respiratory syndrome-associated coronavirus spike protein.
    Wang C; Ren X
    Hybridoma (Larchmt); 2010 Dec; 29(6):511-6. PubMed ID: 21087096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.